Evidence map›Paper›PMID 31235685›Full record

ArticleCell death & disease2019

Preso regulates NMDA receptor-mediated excitotoxicity via modulating nitric oxide and calcium responses after traumatic brain injury.

Peng Luo, Xin Li, Xiuquan Wu, Shuhui Dai, Yuefan Yang, Haoxiang Xu, Da Jing, Wei Rao, Hongyu Xu, Xiangyu Gao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Parkin protects against traumatic brain injury through regulating mitochondrial quality control.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. ILBInternational journal of molecular sciences · 2022
    Article
  17. Review
  18. The Development of Novel Drug Treatments for Stroke Patients: A Review.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Peng LuoDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xin LiDepartment of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiuquan WuDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Shuhui DaiDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yuefan YangDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Haoxiang XuDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Da JingDepartment of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
Wei RaoDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Hongyu XuDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Xiangyu GaoDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhou FeiDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China. zhoufei@fmmu.edu.cn.
Hongbing LuDepartment of Biomedical Engineering, Fourth Military Medical University, Xi'an, China. luhb@fmmu.edu.cn.
Xijing Hospital · CNAir Force Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic brain injury (TBI) has become a major health concern worldwide, and the poor outcome of TBI increases the need for therapeutic improvement. Secondary injuries following TBI, including excitotoxicity, lead to synaptic dysfunction and provide potential targets for intervention. Postsynaptic scaffold proteins, which are involved in the regulation of excitotoxicity after neuronal injury, play a crucial role in modulating synaptic function. Therefore, exploring the role of postsynaptic scaffold proteins in TBI might uncover new treatments. In this study, we demonstrated that downregulated expression of the postsynaptic scaffold protein Preso protects against neuronal injury after TBI in vitro and in vivo, and these effects are related to the inhibition of N-methyl-D-aspartate receptor (NMDAR) function. Further study showed that Preso facilitates signaling from NMDAR to nitric oxide (NO) and calcium (Ca

Indexed as

AnimalsBlotting, WesternBrain Injuries, TraumaticCalciumCell DeathCells, CulturedCyclin-Dependent Kinase 5Disks Large Homolog 4 ProteinImmunoprecipitationIntracellular Signaling Peptides and ProteinsLentivirusMiceMice, Inbred C57BLNitric OxidePhosphorylationReceptors, N-Methyl-D-AspartateCalciumCdk5 protein, mouseCyclin-Dependent Kinase 5Disks Large Homolog 4 ProteinIntracellular Signaling Peptides and ProteinsNitric OxideReceptors, N-Methyl-D-Aspartate

Identifiers

PMID31235685
PMCPMC6591282
OpenAlexW2950951682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.